Hospital Frequency and Factors Associated with Peripheral Neuropathy in Diabetic Patients at the Libreville Hospital University in 2022

<i>Introduction:</i> Diabetes represents a major public health issue worldwide due to its prevalence and numerous complications. The progression of this chronic disease is marked by complications, the most common of which is peripheral neuropathy. Diabetic peripheral neuropathy results from prolonged exposure of the microcirculation to elevated blood sugar levels. The aim of this study was to determine the prevalence and associated factors of peripheral neuropathy among diabetic patients at the University Hospital Center of Libreville in 2022. <i>Methods:</i> This was a cross-sectional, descriptive and analytical study conducted from June 15 to August 15, 2022. The study population consisted of diabetic patients seen in the endocrinology and neurology outpatient departments at university hospital of Libreville during the study period. The presence of peripheral neuropathy was defined based on two assessment tools: the Michigan Neuropathy Screening Instrument (MNSI) and the DN4 questionnaire. <i>Results:</i> A total of 301 diabetic patients were included in the study. There was a female predominance, with a sex ratio of 0.5. The mean age of the population was 57.4 ± 12.4 years. The hospital prevalence of peripheral neuropathy among diabetic patients at university hospital of Libreville was 43.2%. Painful forms, assessed using the DN4 score, accounted for 23.9%. <i>Conclusion:</i> The study highlights the prominent role of peripheral neuropathy as a complication of diabetes mellitus. Preventive strategies, particularly through glycemic control, appear essential.